Siderosis - 26 Studies Found Completed : Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO). : Sickle Cell Disease : 2010-03-15 : Drug: ICL670 Daily doses of ICL670 were taken orally 30 minutes before breakfast. The doses range from 5 Completed : A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity : Transfusional Iron Overload : 2010-01-05 : Drug: ICL670 Completed : T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients : Thalassemia : 2007-08-23 Completed : Amlodipine for Myocardial Iron in Thalassemia : Thalassemia : 2014-02-17 : Drug: Standard Chelation This Completed : A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months : Multiple Sclerosis : 2012-09-26 : Other: MRI All subjects will undergo a MRI. Completed : Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial : Multiple Sclerosis : 2010-03-10 : Drug: Rebif 44 mcg tiw <<< Previous
